First New York Securities’s Amgen AMGN Stock Holding History

First New York Securities’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-370	Closed	-$56.8K	–	342
2015 Q2	$56.8K	Buy	+370	New	+$59.3K	0.03%	190
2014 Q2	–	Sell	-591	Closed	-$73K	–	197
2014 Q1	$73K	Buy	+591	New	+$71.7K	0.04%	231

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

First New York Securities's AMGN Position: Q3 2015 in Review

First New York Securities sold out of Amgen (AMGN) in Q3 2015, closing a stake of 370 shares — an estimated $56.8K sold.

First New York Securities first reported a position in AMGN in Q1 2014 and held it in 2 quarters. The position peaked at $73K in Q1 2014. 1,382 funds tracked by Wall St. Rank hold AMGN as of Q3 2015.

First New York Securities reported no remaining Amgen position as of Q3 2015 after selling out during the quarter.
First New York Securities sold 370 Amgen shares in Q3 2015, an estimated $56.8K.
First New York Securities first reported a position in Amgen in Q1 2014 and held it in 2 quarters.
First New York Securities's Amgen position peaked at $73K in Q1 2014.
1,382 funds tracked by Wall St. Rank held Amgen as of Q3 2015.

Based on First New York Securities's 13F filing for Q3 2015, filed 27 Oct 2015.